PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS
First Claim
Patent Images
1. A pharmaceutical formulation comprising:
- a) one or more NO-releasing NSAID(s) of formula (I);
b) one or more surfactants wherein the ratio surfactant;
NO-releasing NSAID is from 0.1;
1 to 10;
1;
c) carbonyl scavenger compound selected from free acid forms, salts, carboxylic acid esters derivatives of a compound of formula (II)
H2N—
(CH2)m—
(C6H4)—
COOH wherein m=0-10 wherein the amount of the compound of formula (II) is from about 0.01% to about 5% by weight of the total weight of the composition;
wherein in formula (I) M is selected from the group consisting of X is a spacer, i.e. a compound forming a bridge between the nitrogen oxide donating group and the NSAID, and is selected from i) straight or branched C1-C20 alkylene, preferably C1-C10, being optionally substituted with one or more of the substituents selected from the group consisting of;
halogen atoms, hydroxy, —
ONO2 or T, wherein T is —
OC(O)(C1-C10 alkyl)-ONO2 or —
O(C1-C10 alkyl)-ONO2;
ii) C5-C7 cycloalkylene group optionally substituted with linear or branched C1-C10 alkyl group, preferably CH3;
iii) wherein n is an integer from 0 to 20, preferably n is an integer from 0 to 5; and
n1 is an integer from 1 to 20, preferably n1 is an integer from 1 to 5;
with the proviso that the —
ONO2 group of formula (I) is bound to —
(CH2)n1; and
iv) wherein X2 is —
O—
or —
S—
;
n3 is an integer from 1 to 6, preferably from 1 to 4, and R2 is H or CH3.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a pharmaceutical formulation comprising:
- a) one or more NO-releasing NSAID(s) of formula (I);
- b) one or more surfactants;
- c) a carbonyl scavenger compound selected from free acid forms, salts, carboxylic acid esters derivatives of a compound of formula (II)
H2N—(CH2)m—(C6H4)—COOH (II)
wherein m=0-10; and
- d) optionally an oil or semi-solid fat and/or a short-chain alcohol.
5 Citations
15 Claims
-
1. A pharmaceutical formulation comprising:
-
a) one or more NO-releasing NSAID(s) of formula (I); b) one or more surfactants wherein the ratio surfactant;
NO-releasing NSAID is from 0.1;
1 to 10;
1;c) carbonyl scavenger compound selected from free acid forms, salts, carboxylic acid esters derivatives of a compound of formula (II)
H2N—
(CH2)m—
(C6H4)—
COOHwherein m=0-10 wherein the amount of the compound of formula (II) is from about 0.01% to about 5% by weight of the total weight of the composition; wherein in formula (I) M is selected from the group consisting of X is a spacer, i.e. a compound forming a bridge between the nitrogen oxide donating group and the NSAID, and is selected from i) straight or branched C1-C20 alkylene, preferably C1-C10, being optionally substituted with one or more of the substituents selected from the group consisting of;
halogen atoms, hydroxy, —
ONO2 or T, wherein T is —
OC(O)(C1-C10 alkyl)-ONO2 or —
O(C1-C10 alkyl)-ONO2;ii) C5-C7 cycloalkylene group optionally substituted with linear or branched C1-C10 alkyl group, preferably CH3; iii) wherein n is an integer from 0 to 20, preferably n is an integer from 0 to 5; and
n1 is an integer from 1 to 20, preferably n1 is an integer from 1 to 5;
with the proviso that the —
ONO2 group of formula (I) is bound to —
(CH2)n1; andiv) wherein X2 is —
O—
or —
S—
;n3 is an integer from 1 to 6, preferably from 1 to 4, and R2 is H or CH3. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
12. A pharmaceutical formulation according to claim 1 wherein the NO-releasing NSAID of formula (I) is the compound of formula (IA)
-
13. A pharmaceutical formulation according to claim 12 wherein
b) the surfactants is poloxamer 407 and the ratio surfactant: - compound (Ia) is 0.6;
c) the compound of formula (II) is p-aminobenzoic acid and the amount of p-aminobenzoic acid is about the 0.1% by weight of the total weight of the composition.
- compound (Ia) is 0.6;
-
14. A pharmaceutical formulation according to claim 12 wherein
b) the surfactants is poloxamer 407 and the ratio surfactant: - compound (Ia) is 0.6;
c) the compound of formula (II) is p-aminobenzoic acid and the amount of p-aminobenzoic acid is about the 0.5% by weight of the total weight of the composition.
- compound (Ia) is 0.6;
-
15. A pharmaceutical formulation according to claim 12 also comprising an oil or semi-solid fat and/or a short-chain alcohol.
Specification